Search Results - "Borisevich, Sergey V."

Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies by Ziganshina, Marina M, Shilova, Nadezhda V, Khalturina, Eugenia O, Dolgushina, Natalya V, V Borisevich, Sergey, Yarotskaya, Ekaterina L, Bovin, Nicolai V, Sukhikh, Gennady T

“…Antibody-dependent enhancement (ADE) is a phenomenon where virus-specific antibodies paradoxically cause enhanced viral replication and/or excessive immune…”
Get full text

Comparative analysis of the taxonomic classification criteria for a number of groups of pathogenic DNA and RNA viruses based on genomic data by Sizikova, Tatiana E., Lebedev, Vitaliy N., Borisevich, Sergey V.

“…The basis for criteria of the taxonomic classification of DNA and RNA viruses based on data of the genomic sequencing are viewed in this review. The genomic…”
Get full text

Analysis of aerobiological studies with orthopoxviruses by U.S. Department of Defense by Onishenko, Gennady G., Kirillov, Igor A., Borisevich, Sergey V., Sizikova, Tatiana E., Krotkov, Victor T.

“…Discontinuation of vaccination after the completion of Smallpox global eradication program led to a sharp decrease in the level of collective immunity not only…”
Get full text

The use of immunoglobulins and monoclonal antibodies against COVID-19 by Popadyuk, Elena E., Sizikova, Tatyana E., Khmelev, Aleksey L., Timofeev, Mikhail A., Lebedev, Vitaliy N., Borisevich, Sergey V.

“…Introduction. When a new disease occurs, one of the most affordable remedies is drugs containing specific antibodies to this infectious agent. The use of such…”
Get full text

Vaccines to prevent Ebola virus disease: current challenges and perspectives by Kovyrshina, Anna V., Sizikova, Tatiana E., Lebedev, Vitaliy N., Borisevich, Sergey V., Dolzhikova, Inna V., Logunov, Denis Yu, Gintsburg, Alexander L.

“…Relevance. Ebola virus disease (EVD) is an acute infectious disease with an extremely high case fatality rate reaching up to 90%. EVD has become widely known…”
Get full text

Using the vaccinia virus MVA strain for developing recombinant vector vaccines against current arboviral infections by Stovba, L. F., Krotkov, V. T., Melnikov, S. A., Paveliev, D. I., Chernikova, N. K., Borisevich, S. V.

“…Epidemic vector-borne viral infections pose a serious threat to public health worldwide. There is currently no specific preventive treatment for most of them…”
Get full text

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection by Esmagambetov, I B, Shcheblyakov, D V, Egorova, D A, Voronina, O L, Derkaev, A A, Voronina, D V, Popova, O, Ryabova, E I, Shcherbinin, D N, Aksenova, E I, Semenov, A N, Kunda, M S, Ryzhova, N N, Zubkova, O V, Tukhvatulin, A I, Logunov, D Yu, Naroditsky, B S, Borisevich, S V, Gintsburg, A L

“…Ebola fever is an acute, highly contagious viral disease with a mortality rate that can reach 90%. There are currently no licensed therapeutic agents specific…”
Get full text

Buffalopox by Borisevich, Sergey V, Marennikova, S S, Stovba, L F, Petrov, A A, Krotvov, V T, Makhlai, A A

“…Buffalopox is a contagious viral disease affecting milch buffaloes (Bubalus Bubalis) and, rarely, cows. The disease has zoonotic implications, as outbreaks are…”
Get full text